| Class . | Illicit drug . | Metabolite . | Excretion rate/excretion factor . | Reference . |
|---|---|---|---|---|
| Cocainics | Cocaine | Benzoylecgonine (BE) | 30.58% (BE)/0.075 | [4, 16] |
| Opioids | Morphine | – | 48% (after heroin intake)/–; 74.6% (after morphine intake)/ – | [17] |
| Methadone | 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | 19.7% (methadone)/ –; 25% (EDDP)/ – | [18] | |
| Amphetamine | Amphetamine | – | 29.12%/0.394 | [4, 14] |
| derivatives | Methamphetamine | – | 28.56%/0.39 | [4, 14] |
| 3,4-Methylenedixoymethamphetamine (MDMA) | – | 15.78%/0.225 | [4, 14] | |
| New psychoactive | Mephedrone | – | – | – |
| substances (NPS) | Methylone | – | – | – |
| Class . | Illicit drug . | Metabolite . | Excretion rate/excretion factor . | Reference . |
|---|---|---|---|---|
| Cocainics | Cocaine | Benzoylecgonine (BE) | 30.58% (BE)/0.075 | [4, 16] |
| Opioids | Morphine | – | 48% (after heroin intake)/–; 74.6% (after morphine intake)/ – | [17] |
| Methadone | 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | 19.7% (methadone)/ –; 25% (EDDP)/ – | [18] | |
| Amphetamine | Amphetamine | – | 29.12%/0.394 | [4, 14] |
| derivatives | Methamphetamine | – | 28.56%/0.39 | [4, 14] |
| 3,4-Methylenedixoymethamphetamine (MDMA) | – | 15.78%/0.225 | [4, 14] | |
| New psychoactive | Mephedrone | – | – | – |
| substances (NPS) | Methylone | – | – | – |
| Class . | Illicit drug . | Metabolite . | Excretion rate/excretion factor . | Reference . |
|---|---|---|---|---|
| Cocainics | Cocaine | Benzoylecgonine (BE) | 30.58% (BE)/0.075 | [4, 16] |
| Opioids | Morphine | – | 48% (after heroin intake)/–; 74.6% (after morphine intake)/ – | [17] |
| Methadone | 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | 19.7% (methadone)/ –; 25% (EDDP)/ – | [18] | |
| Amphetamine | Amphetamine | – | 29.12%/0.394 | [4, 14] |
| derivatives | Methamphetamine | – | 28.56%/0.39 | [4, 14] |
| 3,4-Methylenedixoymethamphetamine (MDMA) | – | 15.78%/0.225 | [4, 14] | |
| New psychoactive | Mephedrone | – | – | – |
| substances (NPS) | Methylone | – | – | – |
| Class . | Illicit drug . | Metabolite . | Excretion rate/excretion factor . | Reference . |
|---|---|---|---|---|
| Cocainics | Cocaine | Benzoylecgonine (BE) | 30.58% (BE)/0.075 | [4, 16] |
| Opioids | Morphine | – | 48% (after heroin intake)/–; 74.6% (after morphine intake)/ – | [17] |
| Methadone | 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | 19.7% (methadone)/ –; 25% (EDDP)/ – | [18] | |
| Amphetamine | Amphetamine | – | 29.12%/0.394 | [4, 14] |
| derivatives | Methamphetamine | – | 28.56%/0.39 | [4, 14] |
| 3,4-Methylenedixoymethamphetamine (MDMA) | – | 15.78%/0.225 | [4, 14] | |
| New psychoactive | Mephedrone | – | – | – |
| substances (NPS) | Methylone | – | – | – |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
